Calumet (CLMT) Gains from Sales and Divestitures (2022 - 2025)
Calumet (CLMT) has disclosed Gains from Sales and Divestitures for 4 consecutive years, with $898911.0 as the latest value for Q4 2025.
- Quarterly Gains from Sales and Divestitures rose 338.33% to $898911.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $898911.0 through Dec 2025, up 338.33% year-over-year, with the annual reading at $898911.0 for FY2025, 338.33% up from the prior year.
- Gains from Sales and Divestitures for Q4 2025 was $898911.0 at Calumet, up from $205074.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $1.7 million in Q4 2022, with the low at $205074.0 in Q4 2024.
- Average Gains from Sales and Divestitures over 4 years is $988827.5, with a median of $1.0 million recorded in 2023.
- The sharpest move saw Gains from Sales and Divestitures plummeted 82.08% in 2024, then skyrocketed 338.33% in 2025.
- Over 4 years, Gains from Sales and Divestitures stood at $1.7 million in 2022, then plummeted by 32.94% to $1.1 million in 2023, then tumbled by 82.08% to $205074.0 in 2024, then surged by 338.33% to $898911.0 in 2025.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $898911.0, $205074.0, and $1.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.